MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Primary Peritoneal Carcinoma

  1. Home
  2. Diseases
  3. Primary Peritoneal Carcinoma
  4. Clinical Trials

Clinical Trials Related to Primary Peritoneal Carcinoma

Related studies linked through entity extraction aliases.

NCT00072566

Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Status
COMPLETED
Phase
PHASE2

NCT00066456

Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

Status
COMPLETED
Phase
PHASE1

NCT00060359

Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

Status
COMPLETED
Phase
PHASE1

NCT00054119

Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Status
COMPLETED
Phase
PHASE2

NCT00045682

CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Status
COMPLETED
Phase
PHASE2

NCT00011986

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Status
COMPLETED
Phase
PHASE3

NCT00004221

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer

Status
TERMINATED
Phase
PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.